Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$24,448
+$619 QoQ
Shares Held
156
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,487
of 1,603 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westfuller Advisors, LLC holds $6,642,407 across 13 Drug Manufacturers - General names. NVS ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,413 | $2,644,589 | |
| 2 | LLY |
ELI LILLY & Co
|
2,096 | $2,514,005 | |
| 3 | ABBV |
AbbVie Inc.
|
1,648 | $414,702 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,016 | $387,556 | |
| 5 | AMGN |
Amgen Inc
|
861 | $311,785 | |
| 6 | PFE |
Pfizer Inc
|
5,206 | $125,360 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
926 | $116,990 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
874 | $50,359 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,448 | 156 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $23,829 | 156 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $224,452 | 1,628 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $208,774 | 1,628 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||